
This chapter of the annual 2008 AVAC report addresses the following questions: Is NIAID spending wisely? Should the next planned efficacy trial, PAVE 100, go forward? Are T-cell vaccines dead? Is an AIDS vaccine possible?
This chapter of the annual 2008 AVAC report addresses the following questions: Is NIAID spending wisely? Should the next planned efficacy trial, PAVE 100, go forward? Are T-cell vaccines dead? Is an AIDS vaccine possible?